MAIA Biotechnology Inc.

1.60
-0.03 (-1.84%)
At close: Mar 28, 2025, 3:59 PM
1.62
1.25%
After-hours: Mar 28, 2025, 06:55 PM EDT

MAIA Biotechnology Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a n/a n/a n/a n/a
Cost of Revenue n/a n/a n/a n/a n/a n/a
Gross Profit n/a n/a n/a n/a n/a n/a
Operating Income -16.96M -20.18M -16.18M -7.79M -6.98M -6.92M
Interest Income 318.37K 27.63K 1.87K 2.01K 679.00 242.00
Pretax Income -23.25M -19.77M -15.77M -12.58M -6.96M -6.92M
Net Income -23.25M -19.77M -15.81M -13.29M -6.67M -6.49M
Selling & General & Admin 6.95M 9.07M 6.14M 4.29M 5.56M 5.01M
Research & Development 10.01M 11.11M 8.62M 3.45M 1.41M 1.91M
Other Expenses n/a n/a 1.1M n/a n/a n/a
Operating Expenses 16.96M 20.18M 15.86M 7.74M 6.98M 6.92M
Interest Expense -57 n/a 6.97K 827.54K 32.23K n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a 5M
Cost & Expenses n/a 20.18M 15.86M 7.74M 6.98M 6.92M
Income Tax n/a n/a 36.69K 707.53K -291.04K -435.25K
Shares Outstanding (Basic) 22.2M 13.26M 9.28M 10.64M 10.64M 10.64M
Shares Outstanding (Diluted) 22.2M 13.26M 9.28M 10.64M 10.64M 10.64M
EPS (Basic) -1.05 -1.49 -1.7 -1.25 -0.63 -0.61
EPS (Diluted) -1.05 -1.49 -1.7 -1.25 -0.63 -0.61
EBITDA -16.96M -20.18M -16.18M n/a n/a 242.00
Depreciation & Amortization n/a 2.00 1.00 7.79M 6.98M 6.92M